The benefit of adjuvant chemotherapy in elderly patients with stage III colorectal cancer is independent of age and comorbidity

While stage III CRC patients with increasing age and comorbidity are less likely to receive chemotherapy, receipt of chemotherapy is associated with a lower risk of death.